{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:25:43Z","timestamp":1790018743353,"version":"4.0.1"},"reference-count":31,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2005,9,30]],"date-time":"2005-09-30T00:00:00Z","timestamp":1128038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To identify a finer level of antibody specificity for risk of congenital heart block (CHB) than reactivity to 52\u2010kd SSA\/Ro (Ro 52).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum from mothers enrolled in the Research Registry for Neonatal Lupus and the observational PR Interval and Dexamethasone Evaluation (PRIDE) study was evaluated for reactivity against peptide aa200\u2010239 of Ro 52 (p200), recently reported to be associated with a higher risk of CHB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The majority of 156 Ro 52\u2013positive sera tested were reactive with p200 (&gt;3 SD above control), irrespective of the clinical status of the child. Optical density (OD) values of p200 did not differ significantly among mothers of children with CHB (mean \u00b1 SD 0.187 \u00b1 0.363), mothers of children with rash (mean \u00b1 SD 0.176 \u00b1 0.356), and mothers of children without neonatal lupus (mean \u00b1 SD 0.229 \u00b1 0.315). Reactivity against p200 was found in 80 of 104 mothers of children with CHB (77%), 24 of 30 mothers of children with rash (80%), and 21 of 22 mothers who delivered healthy children and had no children with neonatal lupus (95%) (<jats:italic>P<\/jats:italic> not significant for all comparisons). Sera from 4 mothers of children with CHB with varied p200 titers (OD range 0.025\u20131.818) bound to the surface of nonpermeabilized apoptotic, but not proliferating, human fetal cardiocytes. In 32 Ro 52\u2013positive women who completed the PRIDE study (22 with no child with neonatal lupus, 7 with a child with CHB, and 3 with a child with rash) in whom p200 levels were determined during pregnancy, the correlation between level of p200 (OD range 0.000\u20131.170) and maximal fetal PR interval (range 115\u2013168 msec) was not significant (\u03c1 = 0.107, <jats:italic>P<\/jats:italic> = 0.58).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Reactivity to p200 is a dominant but not uniform anti\u2013Ro 52 response in women whose children have CHB. Since exposure to this antibody specificity was observed with a similar frequency in children without CHB born to mothers with anti\u2013Ro 52, additional factors are necessary to convert risk to disease expression.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.21289","type":"journal-article","created":{"date-parts":[[2005,9,30]],"date-time":"2005-09-30T18:47:44Z","timestamp":1128106064000},"page":"3079-3086","source":"Crossref","is-referenced-by-count":61,"title":["Maternal antibody responses to the 52\u2010kd SSA\/RO p200 peptide and the development of fetal conduction defects"],"prefix":"10.1002","volume":"52","author":[{"given":"Robert M.","family":"Clancy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionne A.","family":"Argyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K. L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,9,30]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C"},{"key":"e_1_2_6_3_2","first-page":"2480","article-title":"Anti\u201052 kDa Ro, anti\u201060 kDa Ro, and anti\u2010La antibody profiles in neonatal lupus","volume":"31","author":"Gordon P","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2005.01.010"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.4049\/jimmunol.152.7.3675","article-title":"Autoantibody responses to the \u201cnative\u201d 52\u2010kDa SS\u2010A\/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sj\u00f6gren's syndrome","volume":"152","author":"Buyon JP","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780361114"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10232"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041859"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00161-2"},{"key":"e_1_2_6_11_2","first-page":"925","article-title":"Subclass distribution of maternal and neonatal anti\u2010Ro(SSA) and La(SSB) antibodies in congenital heart block","volume":"23","author":"Tseng CE","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400523"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00867-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000074256"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90837-8"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199902000-00018"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.9.5061"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.4.2156"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-7-199404010-00003"},{"key":"e_1_2_6_20_2","first-page":"1101","article-title":"Congenital heart block and neonatal lupus erythematosus: prevention is the goal","volume":"20","author":"Silverman ED","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_6_21_2","first-page":"11","article-title":"Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block","volume":"82","author":"Julkunen H","year":"1993","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20126"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20738"},{"key":"e_1_2_6_24_2","first-page":"373","article-title":"Primary Sj\u00f6gren's syndrome: treatment of fetal incomplete atrioventricular block with dexamethasone","volume":"28","author":"Theander E","year":"2001","journal-title":"J Rheumatol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/rhe.31.3.133.139"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01048-2"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203302lu173oa"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu466ed"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.6.3253"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11430"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1067\/mje.2002.121438"},{"key":"e_1_2_6_32_2","volume-title":"Moss and Adams heart disease in infants, children and adolescents","author":"Allen HD","year":"2001"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.21289","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.21289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T06:47:15Z","timestamp":1697006835000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.21289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,30]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1002\/art.21289"],"URL":"https:\/\/doi.org\/10.1002\/art.21289","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,30]]}}}